2Sairenji T,Ohnishi E,Inouye S,et al.Induction of interleukin-10 on activation of Epatein-Barr virus in EBV-infected B-cell lines. Viral Immunology . 1998
3Muller A,Schmitt L,Raftery M,et al.Paralysis of B7 co-stimulation through the effect of viral IL-10 on T cells as a mechamism of local tolerance induction. European Journal of Immunology . 1998
4Straus SE,Cohen JI,Tosato G,et al.NIH conference Epstein-Barr virus infections: biology, pathogenesis and management. Annals of Internal Medicine . 1993
5Spriggs MK,Armitage RJ,Comeau MR,et al.The extracellular domain of the Epstein-Barr virus BZLF2 protein binds the HLA-DR beta chain and inhibits antigen presentation. Journal of Virology . 1996
6Lee MA,Diamond ME,Yates JL.Genetic evidence that EBNA-1 is needed for efficient, stable latent infection by Epstein-Ban virus. Journal of Virology . 1999
7Zdanov A,Schalk Hihi C,Menon S,et al.Crystal structure of Epstein-Barr virus protein BCRF1, a homolog of cellular interleukin-10. Journal of Molecular Biology . 1997
8Rooney CM,Rowe M,Wallace LE,et al.Epstein-Barr virus-positive Burkitt’s lymphoma cells not recognized by virus-specific T-cell surveillance. Nature . 1985
9Henderson S,Huen D,Rowe M,et al.Epstein-Barr virus-encoded BHRF1 protein, a virus homologue of Bcl-2, protects human B cells from programmed cell death. Proceedings of the National Academy of Sciences of the United States of America . 1993
10de Campos-Lima PO,Levitshy V,Brooks J,et al.T cell responses and virus evolution:loss of HLA All-restricted CTL epitopes in Epstein-Barr virus isolates from highly A1 1-positive populations by selective mutation of anchor residues. The Journal of Experimental Medicine . 1994
